Case Rport L.C. was born at St. Mary's Hospital on June 14, 1962, the second child of a healthy 23-year-old woman who had been well during pregnancy. Delivery was normal, the birth weight was 7 lb. 10 oz. (3 5 kg.), and the baby breathed and cried at once but appeared rather pale.
Next day, pallor had increased and there was abdominal distension caused by firm enlargement of the liver. The For a time his condition remained poor, and increasing abdominal distension, due partly to increase in size of the liver and partly to ascites, caused moderate respiratory embarrassment. Oedema of the legs, abdomen, arms, and face became marked. It was noticed that the circumference of the right upper arm was slightly larger than the left. A bone-marrow biopsy from the right tibia at 24 days of age showed no abnormal cells. His haemoglobin tended to fall, and he required three small blood transfusions, the first at the time of laparotomy.
At the age of 6 days a 24-hour collection of urine was assayed for catecholamine metabolites: the output of 4-hydroxy-3-methoxymandelic acid (VMA) was 17 4 mg. and that of 4-hydroxy-3-methoxyphenylacetic acid (HVA) 9 4 mg., using the methods, respectively, of Pisano, Crout and Abraham (1962) and of Ruthven and Sandler (1962 (Table) . The specimens at 3 months of age and subsequently have shown normal levels for a child in this age-group.
The child has continued to thrive with normal motor and mental development, and now, at the age of 17 months, appears a healthy happy boy.
Since the age of 3 months his B 12 injections have been reduced to alternate days, and since 7 months have been given successfully by his mother, whose intelligent co-operation has made possible his management at home.
Discussion
The treatment of neuroblastoma with vitamin B 12 is controversial. Although a dramatic response to such treatment was claimed by Bodian (1959) , his findings have not been confirmed by King et al. (1961) or by Dargeon (1960) . Bachmann (1962) has recently collected 1,030 cases of neuroblastoma from the literature and has shown that clinical cure, ascribed to a variety of therapeutic regimens, was claimed for 25%. It appears that many of these cures were due to spontaneous regression of tumour tissue. The younger the age of onset, the more likely is such regression to occur. It is therefore not possible in the present case to claim more than a fortuitous association between vitamin B 12 treatment and the clinical outcome.
Several workers have used the biochemical activity of the tumour, as reflected by the urinary excretion of catecholamines and their metabolites, to chart the clinical progress of the patient (Greenberg and Gardner, 1960; von Studnitz, 1960; von Studnitz et al., 1963; Smellie and Sandler, 1961; Voorhess and Gardner, 1961, 1962a, b; Bettex and Kaser, 1962; Kontras, 1962; Young, Steiker, Bongiovanni, Koop and Eberlein, 1963; Sourkes et al., 1963; Rosenstein and Engelman, 1963; Williams and Greer, 1963) . Williams and Greer (1962, 1963) have pointed out from their own experiences and from a study of the literature that the measurement of HVA, the major metabolite of dopamine, and of VMA, the major metabolite of noradrenaline, provide sufficient information to make a diagnosis in most cases of this secreting tumour.
In the patient described here, comparatively vast concentrations of these metabolites were excreted in the urine initially. Coinciding with an improvement in the patient's clinical state and with tumour regression, levels gradually fell to normal, providing valuable biochemical confirmation of apparent clinical cure.
Summary
A case of congenital neuroblastoma of unknown origin with multiple hepatic metastases is reported. Regression of the tumour was associated with a return to normal of the initially very high levels of 4-hydroxy-3-methoxymandelic acid (VMA) and 4-hydroxy-3-methoxyphenylacetic acid (HVA) in the urine. These values have remained within normal limits up to the age of 17 months.
